SP
IDXX icon

Symmetry Partners’s Idexx Laboratories IDXX Stock Holding History

Symmetry Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Buy
560
+44
+9% +$24.7K 0.02% 182
2026
Q1 		$290K Sell
516
-1
-0.2% -$641 0.02% 149
2025
Q4 		$350K Sell
517
-3
-0.6% -$2.04K 0.02% 123
2025
Q3 		$332K Buy
520
+24
+5% +$14.6K 0.04% 112
2025
Q2 		$266K Buy
+496
New +$237K 0.03% 121
2024
Q3 		– Sell
-1,375
Closed -$670K – 287
2024
Q2 		$670K Hold
1,375
– – 0.03% 226
2024
Q1 		$742K Hold
1,375
– – 0.06% 226
2023
Q4 		$766K Sell
1,375
-138
-9% -$64.8K 0.04% 209
2023
Q3 		$662K Hold
1,513
– – 0.04% 246
2023
Q2 		$760K Hold
1,513
– – 0.04% 237
2023
Q1 		$757K Hold
1,513
– – 0.04% 227
2022
Q4 		$617K Hold
1,513
– – 0.04% 276
2022
Q3 		$493K Hold
1,513
– – 0.03% 307
2022
Q2 		$531K Hold
1,513
– – 0.04% 301
2022
Q1 		$828K Hold
1,513
– – 0.05% 233
2021
Q4 		$996K Sell
1,513
-218
-13% -$137K 0.06% 211
2021
Q3 		$1.06M Hold
1,731
– – 0.07% 206
2021
Q2 		$1.09M Hold
1,731
– – 0.07% 208
2021
Q1 		$847K Sell
1,731
-67
-4% -$33.6K 0.06% 241
2020
Q4 		$899K Buy
1,798
+7
+0.4% +$3.13K 0.07% 205
2020
Q3 		$704K Buy
1,791
+1,111
+163% +$411K 0.06% 227
2020
Q2 		$225K Buy
+680
New +$197K 0.03% 277
2019
Q4 		– Sell
-821
Closed -$223K – 348
2019
Q3 		$223K Sell
821
-266
-24% -$74K 0.05% 305
2019
Q2 		$299K Sell
1,087
-454
-29% -$112K 0.06% 249
2019
Q1 		$345K Hold
1,541
– – 0.06% 220
2018
Q4 		$287K Buy
+1,541
New +$316K 0.07% 198

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Symmetry Partners's IDXX Position: Q2 2026 in Review

Symmetry Partners increased its Idexx Laboratories (IDXX) stake by 8.5% in Q2 2026, buying an estimated $24.7K and bringing the position to 560 shares worth $295K. The position accounts for 0.02% of the portfolio, ranked #182.

Symmetry Partners first reported a position in IDXX in Q4 2018 and has held it in 26 quarters since. The position peaked at $1.09M in Q2 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Symmetry Partners held 560 shares of Idexx Laboratories worth $295K as of Q2 2026.
  • Symmetry Partners bought 44 Idexx Laboratories shares in Q2 2026, an estimated $24.7K.
  • Idexx Laboratories made up 0.02% of Symmetry Partners's portfolio in Q2 2026, its #182 holding.
  • Symmetry Partners first reported a position in Idexx Laboratories in Q4 2018 and has held it in 26 quarters since.
  • Symmetry Partners's Idexx Laboratories position peaked at $1.09M in Q2 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.